These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16087811)

  • 21. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit.
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):498-9. PubMed ID: 18819148
    [No Abstract]   [Full Text] [Related]  

  • 23. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory response to drug-eluting stent placement.
    Aggarwal A
    Am J Cardiol; 2006 Nov; 98(9):1299. PubMed ID: 17056355
    [No Abstract]   [Full Text] [Related]  

  • 25. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atheromatous showers, periprocedural myocardial infarction, and fatality.
    Yen MH; Topol EJ
    Am Heart J; 2003 Jun; 145(6):933-5. PubMed ID: 12796744
    [No Abstract]   [Full Text] [Related]  

  • 27. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
    Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
    Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic and prognostic significance of CK-MB, troponins, CRP, BNP and/or NT-proBNP in coronary angioplasty. Elevation mechanisms and clinical implications].
    Bertinchant JP; Ledermann B; Schmutz L; Pezzano M; Jamaleddin N; Cade S; Winum PF; Polge A
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):925-33. PubMed ID: 18209693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis.
    Merla R; Reddy NK; Wang FW; Uretsky BF; Barbagelata A; Birnbaum Y
    Am J Cardiol; 2007 Sep; 100(5):770-6. PubMed ID: 17719318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation of plasma brain natriuretic peptide to serum creatine kinase MB level in patients with acute myocardial infarction following primary percutaneous coronary intervention].
    Xiao ZH; Yang XL; Tan HB; Chen J; Xu ZY; Zhang JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1665-6. PubMed ID: 17121728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periprocedural myocardial infarction: prevalence, prognosis, and prevention.
    Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2010 Dec; 3(6):602-10. PubMed ID: 21156928
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
    J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
    Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic criteria for percutaneous coronary intervention-related myocardial infarction: time for revision?
    Lippi G; Cervellin G
    J Am Coll Cardiol; 2011 Jul; 58(3):312-3; author reply 313. PubMed ID: 21737027
    [No Abstract]   [Full Text] [Related]  

  • 39. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis.
    Ajani AE; Waksman R; Sharma AK; Lew R; Pinnow E; Canos DA; Cheneau E; Castagna M; Cha DH; Leborgne L; Satler LF; Pichard AD; Kent KM; Lindsay J
    Am J Cardiol; 2004 Feb; 93(3):313-7. PubMed ID: 14759380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction.
    Garot P; Lefevre T; Eltchaninoff H; Morice MC; Tamion F; Abry B; Lesault PF; Le Tarnec JY; Pouges C; Margenet A; Monchi M; Laurent I; Dumas P; Garot J; Louvard Y
    Circulation; 2007 Mar; 115(11):1354-62. PubMed ID: 17353440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.